Evidence map›Paper›PMID 37347834›Full record

ArticleCirculation research2023

DRP1-Mediated Mitophagy: Safeguarding Obese Hearts From Cardiomyopathy.

Xi Fang, Åsa B Gustafsson

Open access · greenAbstract readEditorialComment
In one paragraph

Article in Circulation research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Oxidative Modifications in Cardiac Mitochondrial and CaHandbook of experimental pharmacology · 2026
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Xi FangDepartment of Medicine (X.F.), University of California San Diego, La Jolla, CA.ORCID 0000-0001-7816-8821
Åsa B GustafssonDepartment of Pharmacology, Skaggs School of Pharmacy and Pharmaceutical Sciences (Å.B.G.), University of California San Diego, La Jolla, CA.ORCID 0000-0001-6347-8210
University of California San Diego · USUniversity of Montana · US

Funding

NEDD4 in right ventricular developmentR01HL158761 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FANG, XI · 2021 to 2025
$2.5M
Secretion of mitochondria as a cellular quality control mechanismR01HL155281 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GUSTAFSSON, ASA B. · 2021 to 2024
$2.3M
Molecular mechanisms and treatment of cardiomyopathy in Barth SyndromeR01HL157115 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FANG, XI · 2021 to 2025
$2.0M
Autophagy and Megamitochondria in Cardiac Aging and Heart FailureR01HL157265 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GUSTAFSSON, ASA B. · 2021 to 2024
$1.9M
Mediator complex in cardiac development and functionR00HL143210 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FANG, XI · 2020 to 2022
$736k
NHLBI NIH HHS R00 HL143210NHLBI NIH HHS R01 HL155281NHLBI NIH HHS R01 HL157115NHLBI NIH HHS R01 HL157265NHLBI NIH HHS R01 HL158761
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CardiomyopathiesMitophagyDynaminsHeartHumansMitochondrial DynamicsDynaminscardiovascular diseasesEditorialheartmitochondria, mitophagyobesity

Identifiers

PMID37347834
PMCPMC10338021
OpenAlexW4381612984

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.